ConductScience.org, home

Paper28650

Salazopyrin in rheumatoid arthritis.

McConkey B and 5 others. Agents Actions, 1978. Cited by 91 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Salazopyrin in rheumatoid arthritis. Papers, record 28650. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28650

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Salazopyrin in rheumatoid arthritis.
PubMed
Journal
Agents Actions
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
3.94
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McConkey BB
2Amos RSR S
3Butler EPE P
4Crockson RAR A
5Crockson APA P
6Walsh LL

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
SulfasalazineMajor topic
Blood Sedimentation
C-Reactive Protein
Female
Humans
Male
Middle Aged

Source PubMed

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,561,431The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.Q J Med1972https://conductscience.org/library/papers/4561431PubMed
24,116,086Pathology, pathogenesis, and aetiology of rheumatoid arthritis.Ann Rheum Dis1972https://conductscience.org/library/papers/4116086PubMed
34,146,086Pharmacokinetics and azo-link cleavage of salazopyrine in man.Gut1973https://conductscience.org/library/papers/4146086PubMed
521,720Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.Br Med J1977https://conductscience.org/library/papers/21720PubMed
6788,118Dapsone in rheumatoid arthritis.Rheumatol Rehabil1976https://conductscience.org/library/papers/788118PubMed
774,460Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease.Lancet1976https://conductscience.org/library/papers/74460PubMed
9647,307Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.Br Med J1978https://conductscience.org/library/papers/647307PubMed
1014,466,713Sulfapyridine and sulfone type drugs in dermatology.Arch Dermatol1962https://conductscience.org/library/papers/14466713PubMed
11832,072Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.Br Med J1977https://conductscience.org/library/papers/832072PubMed
1417,446Megaloblastic anaemia associated with sulphasalazine treatment.Br Med J1977https://conductscience.org/library/papers/17446PubMed
1514,238,065COMPARISON OF ACETARSOL AND PREDNISOLONE-21-PHOSPHATE SUPPOSITORIES IN THE TREATMENT OF IDIOPATHIC PROCTITIS.Lancet1965https://conductscience.org/library/papers/14238065PubMed
164,370,457The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis.Q J Med1973https://conductscience.org/library/papers/4370457PubMed

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
37,431,434Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD).Rheumatol Adv Pract2023https://conductscience.org/library/papers/37431434PubMed
31,831,878Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases.Nat Rev Rheumatol2020https://conductscience.org/library/papers/31831878PubMed
18,475,455Mechanism of action of 5-arninosalicylic acid.Mediators Inflamm1992https://conductscience.org/library/papers/18475455PubMed
11,945,114Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.Drug Saf2002https://conductscience.org/library/papers/11945114PubMed
10,796,400Sulfasalazine for rheumatoid arthritis.Cochrane Database Syst Rev2000https://conductscience.org/library/papers/10796400PubMed
7,588,084Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.Drugs1995https://conductscience.org/library/papers/7588084PubMed
7,363,012Polypharmacy in rheumatic diseases.Br Med J1980https://conductscience.org/library/papers/7363012PubMed
6,142,116Sulphasalazine in rheumatoid arthritis: an old drug revived.J R Soc Med1984https://conductscience.org/library/papers/6142116PubMed
6,138,117Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6138117PubMed
6,138,116Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6138116PubMed
6,106,520Do drugs change the course of rheumatoid arthritis?Br Med J1980https://conductscience.org/library/papers/6106520PubMed
6,102,877Sulphasalazine in rheumatoid arthritis.Br Med J1980https://conductscience.org/library/papers/6102877PubMed
3,284,488Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine.Ann Rheum Dis1988https://conductscience.org/library/papers/3284488PubMed
2,901,303Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.Clin Rheumatol1988https://conductscience.org/library/papers/2901303PubMed
2,894,913Sulphasalazine in arthritis--an old drug rediscovered.Clin Rheumatol1987https://conductscience.org/library/papers/2894913PubMed
2,883,940Sulphasalazine and regression of rheumatoid nodules.Ann Rheum Dis1987https://conductscience.org/library/papers/2883940PubMed
2,877,858Sulphasalazine in the long term management of rheumatoid arthritis.Drugs1986https://conductscience.org/library/papers/2877858PubMed
2,877,854Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.Drugs1986https://conductscience.org/library/papers/2877854PubMed
2,877,8515-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?Drugs1986https://conductscience.org/library/papers/2877851PubMed
2,877,850Pharmacological and biochemical actions of sulphasalazine.Drugs1986https://conductscience.org/library/papers/2877850PubMed

See all 28 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1,401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28650

GET https://conductscience.org/api/papers/v1/28650/cited_by?page=2